Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Yasser S. Abdel-Ghany"'
Autor:
Yasser S. Abdel-Ghany, Sherine N. Khattab, Omnia M. Ali, Ahmed O. Elzoghby, Mohamed Teleb, Maged W. Helmy, Adnan A. Bekhit
Publikováno v:
Colloids and Surfaces B: Biointerfaces. 188:110824
Despite the clinical approval of few nanomedicines for cancer therapy, some drawbacks still impede their improved efficiency including low drug loading, off-target toxicity and development of multi-drug resistance. Herein, lactoferrin (Lf)-coupled me
Autor:
Dharmarajan Sriram, Yasser S. Abdel-Ghany, Perihan A. Elzahhar, Soad A.M. El-Hawash, Rasha A. Nassra, Manal N. S. Saudi, Nayera W. Hassan, Marwa M. Abdel-Aziz, Azza Ismail
Publikováno v:
Bioorganic Chemistry. 96:103610
TB continues to be a leading health threat despite the availability of powerful anti-TB drugs. We report herein the design and synthesis of various hybrid molecules comprising pyrazine scaffold and various formerly identified anti-mycobacterial moiet
Autor:
Ahmed S.F. Belal, Rasha A. Nassra, Yasser S. Abdel-Ghany, Rana Alaaeddine, Lynn M. Alaeddine, Ahmed F. El-Yazbi, Ghandoura Moussa, Aly A. Hazzaa, Azza Ismail
Publikováno v:
European journal of medicinal chemistry. 144
Click chemistry was used to synthesize a new series of thioquinazolinone molecules equipped with propargyl moiety,1,2,3-triazolyl and isoxazolyl rings. Our design was based on merging pharmacophores previously reported to exhibit COX-2 inhibitory act
Autor:
Yasser S. Abdel-Ghany, Alaa A. El-Tombary, Farid S. G. Soliman, S. A. Shams El-Dine, Ahmad S. F. Belal
Publikováno v:
Medicinal Chemistry Research. 20:865-876
In search for novel anti-cancer and anti-microbial agents with promising pharmacotoxicological profile, the synthesis of some substituted 4-halofuran-2(5H)-ones (8a–l, 9, 11) and derived halogenated quinoxalin-2(1H)-ones (12a–d) is described. Som
Publikováno v:
Letters in Organic Chemistry. 5:316-318
Autor:
Isaac O. Donkor, Yasser S. Abdel-Ghany, Duane D. Miller, Peter F. Kador, Anita Bartoszko-Malik, Tadashi Mizoguchi
Publikováno v:
European Journal of Medicinal Chemistry. 33:15-22
We have synthesized alrestatin derivatives 1–11 possessing acyl benzenesulfonamide groups as surrogates for the carboxylic acid moiety of alrestatin. Most of the compounds were inactive as aldose reductase inhibitors compared to alrestatin, however
Autor:
Peter F. Kador, Yasser S. Abdel-Ghany, Duane D. Miller, Isaac O. Donkor, Anita Bartoszko-Malik, Tadashi Mizoguchi
Publikováno v:
ChemInform. 29
We have synthesized alrestatin derivatives 1–11 possessing acyl benzenesulfonamide groups as surrogates for the carboxylic acid moiety of alrestatin. Most of the compounds were inactive as aldose reductase inhibitors compared to alrestatin, however
Publikováno v:
ChemInform. 39
Autor:
Hayam M. A. Ashour, Yasser S. Abdel Ghany, Adnan A. Bekhit, Azza M. Baraka, Alaa El‐Din A. Bekhit
Publikováno v:
ChemInform. 39
Autor:
Yasser S. Abdel Ghany, Alaa El-Din A. Bekhit, Adnan A. Bekhit, Azza M. Baraka, Hayam M. A. Ashour
Publikováno v:
European journal of medicinal chemistry. 43(3)
Four series of pyrazolyl benzenesulfonamide derivatives have been synthesized. The first series was prepared by cyclization of the intermediate N,N-dimethylaminomethylene-4[3-phenyl-4-(substituted thiosemicarbamoyl hydrazonomethyl)-1H-pyrazol-1-yl]be